Recently, the Selethru PTCA, Selethru NC PTCA, and Selebrek PTCA balloon dilatation catheters, independently developed by Kossel, have been approved by the Federal Service for Surveillance in Healthcare (RZN) of the Russian Federation, officially obtaining market access qualification in Russia, adding another important milestone to the company’s global layout!

The Selethru series balloons have been successfully approved and launched in Asia, the Middle East, South America, North America and other regions successively. With excellent product performance and differentiated clinical layout, they have won recognition from the global market, continuously providing high-quality vascular interventional solutions for clinicians worldwide and bringing health benefits to the majority of patients.

After undergoing strict factory inspections, product testing, document review and other multiple authoritative certification procedures, the successful approval of the Selethru series balloons to enter the Russian market is only the first step for Kossel’s products to benefit Russian patients. In the future, more high-quality products and professional solutions will be delivered to local clinics, helping to improve the level of vascular interventional diagnosis and treatment in the region.

The successful approval of these three products to enter the Russian market marks another important breakthrough in Kossel’s internationalization process and further improves the company’s global market layout. In the future, Kossel will continue to uphold its original aspiration, deeply cultivate the vascular interventional field, continuously promote China’s high-end medical devices to the world, and enable high-quality medical products to benefit more patients globally!